Point72 Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.74M Buy
134,114
+3,156
+2% +$128K 0.01% 1741
2025
Q4
$5.32M Buy
+130,958
New +$5.7M 0.01% 1803
2024
Q1
Sell
-110,779
Closed -$9.87M 2247
2023
Q4
$12.1M Buy
+110,779
New +$11.5M 0.03% 627
2022
Q3
Sell
-5,040
Closed -$483K 1438
2022
Q2
$483K Sell
5,040
-87,131
-95% -$10.5M ﹤0.01% 1191
2022
Q1
$13.7M Buy
92,171
+63,009
+216% +$8.8M 0.05% 429
2021
Q4
$4.13M Sell
29,162
-54,549
-65% -$7.73M 0.02% 708
2021
Q3
$11M Buy
+83,711
New +$11M 0.05% 462
2021
Q1
Sell
-58,556
Closed -$6.56M 991
2020
Q4
$6.56M Sell
58,556
-788,981
-93% -$74.7M 0.03% 533
2020
Q3
$66.7M Sell
847,537
-295,116
-26% -$24.1M 0.34% 66
2020
Q2
$82.3M Buy
1,142,653
+665,606
+140% +$46.3M 0.54% 35
2020
Q1
$27.3M Buy
477,047
+372,250
+355% +$34.3M 0.22% 128
2019
Q4
$11.7M Buy
104,797
+35,031
+50% +$3.73M 0.06% 353
2019
Q3
$6.71M Sell
69,766
-670,310
-91% -$62.9M 0.04% 414
2019
Q2
$63.3M Sell
740,076
-8,335
-1% -$685K 0.33% 71
2019
Q1
$62.3M Buy
748,411
+587,311
+365% +$42.7M 0.28% 82
2018
Q4
$10.3M Buy
+161,100
New +$11M 0.05% 407
2016
Q3
Sell
-284,800
Closed -$13.6M 728
2016
Q2
$13.6M Buy
+284,800
New +$12.1M 0.09% 247
2014
Q3
Sell
-27,100
Closed -$1.2M 664
2014
Q2
$1.2M Buy
+27,100
New +$1.23M 0.01% 599

Other funds holding CNMD

Point72 Asset Management's CNMD Position: Q1 2026 in Review

Point72 Asset Management increased its CONMED (CNMD) stake by 2.4% in Q1 2026, buying an estimated $128K and bringing the position to 134,114 shares worth $4.74M. The position accounts for 0.01% of the portfolio, ranked #1741.

Point72 Asset Management first reported a position in CNMD in Q2 2014 and has held it in 18 quarters since. The position peaked at $82.3M in Q2 2020. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Point72 Asset Management held 134,114 shares of CONMED worth $4.74M as of Q1 2026.
  • Point72 Asset Management bought 3,156 CONMED shares in Q1 2026, an estimated $128K.
  • CONMED made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1741 holding.
  • Point72 Asset Management first reported a position in CONMED in Q2 2014 and has held it in 18 quarters since.
  • Point72 Asset Management's CONMED position peaked at $82.3M in Q2 2020.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.